Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – During transradial percutaneous coronary angiography, access through the left arm requires less fluoroscopy time and radiation dose than access through the right arm,…
NEW YORK (Reuters Health) – Active management of the third stage of labor leads to less blood loss compared to expectant management, without altering the childbirth experience, a…
NEW YORK (Reuters Health) – Protease inhibitors do not prevent complications associated with endoscopic retrograde cholangiopancreatography (ERCP), researchers from Japan report in the December 8th Gastrointestinal Endoscopy. Previous…
NEW YORK (Reuters Health) – Vaginal misoprostol applied prior to intrauterine device (IUD) insertion does not make the procedure go any easier or lessen the patient’s pain, a…
NEW YORK (Reuters Health) – Spironolactone use is associated with improved long-term survival in patients with systolic heart failure, researchers from Japan report in the December American Heart…
NEW YORK (Reuters Health) – Women with latent celiac disease — positive celiac antibodies but a normal small bowel biopsy — may be at increased risk of reproductive…
NEW YORK (Reuters Health) – HCV genotype 4, previously limited to Egypt and parts of Africa, has now spread to southern Europe and other parts of world, an…
NEW YORK (Reuters Health) – Recombinant surfactant protein C based surfactant (rSP-C, Nycomed) provides no benefit in patients with severe direct lung injury, but the information gained may…
NEW YORK (Reuters Health) – By restoring cognitive function in patients with minimal hepatic encephalopathy (MHE), rifaximin treatment also improves their quality of life, investigators in India report.…
